(Q37491183)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19459715%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

review article

1 reference

title

Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19459715%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19459715%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Roberto Cilia

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19459715%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Roberto Cilia

series ordinal

2

1 reference

20 August 2017

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19459715%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19459715%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19459715%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19459715%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

475-488

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19459715%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00002018-200932060-00004

28 January 2020

exact match

0 references

cites work

Pathological gambling associated with dopamine agonist therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200932060-00004

Is the mesocortical dopaminergic system involved in Parkinson disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200932060-00004

Suicide after successful deep brain stimulation for movement disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200932060-00004

Impulse control disorders: clinical characteristics and pharmacological management

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200932060-00004

A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling

21 January 2018

2 references

https://api.crossref.org/works/10.2165%2F00002018-200932060-00004

21 January 2018

12 December 2020

A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200932060-00004

Opioid Antagonists in the Treatment of Impulse-Control Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200932060-00004

Behavioural disorders, Parkinson's disease and subthalamic stimulation

21 January 2018

1 reference

12 December 2020

L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease.

1 reference

12 December 2020

A neural substrate of prediction and reward

1 reference

12 December 2020

Clozapine for dopaminergic-induced paraphilias in Parkinson's disease

1 reference

12 December 2020

Behavioral dopamine signals

1 reference

12 December 2020

Dopamine agonist therapy for Parkinson disease and pathological gambling

1 reference

12 December 2020

Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels.

1 reference

12 December 2020

Lithium may reduce gambling severity in pathological gamblers with bipolar disorder

1 reference

12 December 2020

An open-label trial of escitalopram in the treatment of pathological gambling.

1 reference

12 December 2020

Prevalence of repetitive and reward-seeking behaviors in Parkinson disease

1 reference

12 December 2020

Hypersexuality and paraphilia induced by selegiline in Parkinson's disease: report of 2 cases.

1 reference

12 December 2020

Understanding and treating kleptomania: new models and new treatments

1 reference

12 December 2020

A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling

1 reference

12 December 2020

Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?

1 reference

12 December 2020

Hypersexuality after pallidal surgery in Parkinson disease.

1 reference

12 December 2020

Clinical features associated with impulse control disorders in Parkinson disease

1 reference

12 December 2020

Gambling and substance use disorders: current status and future directions

1 reference

12 December 2020

Reduced reward processing in the brains of Parkinsonian patients.

1 reference

12 December 2020

Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.

1 reference

12 December 2020

Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease.

1 reference

12 December 2020

Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy

1 reference

12 December 2020

Drug therapy for patients with eating disorders

1 reference

12 December 2020

Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons.

1 reference

12 December 2020

Reversible transvestic fetishism in a man with Parkinson's disease treated with selegiline

1 reference

12 December 2020

Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents

1 reference

12 December 2020

N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study.

1 reference

12 December 2020

Opioid antagonists in the treatment of impulse-control disorders.

1 reference

12 December 2020

Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis

1 reference

12 December 2020

Quetiapine in a case with Parkinson disease and pathological gambling

1 reference

12 December 2020

Self-stimulatory behavior associated with deep brain stimulation in Parkinson's disease.

1 reference

12 December 2020

Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experience.

1 reference

12 December 2020

Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism

1 reference

12 December 2020

A pilot placebo-controlled study of fluvoxamine for pathological gambling.

1 reference

12 December 2020

Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography.

1 reference

12 December 2020

Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease.

1 reference

12 December 2020

Individual differences in reward drive predict neural responses to images of food.

1 reference

12 December 2020

Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease

1 reference

12 December 2020

Lithium and valproate treatment of pathological gambling: a randomized single-blind study.

1 reference

12 December 2020

Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease.

1 reference

12 December 2020

Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis

1 reference

12 December 2020

Long-term follow-up of impulse control disorders in Parkinson's disease

1 reference

12 December 2020

Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation

1 reference

12 December 2020

Hypersexuality and hemiballism due to subthalamic infarction

1 reference

12 December 2020

Pathological gambling caused by drugs used to treat Parkinson disease

1 reference

12 December 2020

Reward processing in health and Parkinson's disease: neural organization and reorganization

1 reference

12 December 2020

Problematic gambling on dopamine agonists: Not such a rarity

1 reference

12 December 2020

Obsessive-compulsive spectrum disorders

1 reference

12 December 2020

Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series.

1 reference

12 December 2020

Rapid resolution of dopamine dysregulation syndrome (DDS) after subthalamic DBS for Parkinson disease (PD): a case report

1 reference

12 December 2020

Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease

1 reference

12 December 2020

Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies

1 reference

12 December 2020

Association of dopamine agonist use with impulse control disorders in Parkinson disease

1 reference

12 December 2020

Lithium and topiramate association in the treatment of comorbid pathological gambling and bipolar disorder

1 reference

12 December 2020

Neurobiological mechanisms in the transition from drug use to drug dependence.

1 reference

12 December 2020

WITHDRAWN: Interventions for pathological gambling

1 reference

12 December 2020

Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism

1 reference

12 December 2020

Prevalence of pathological gambling in patients with Parkinson's disease.

1 reference

12 December 2020

Compulsive eating and weight gain related to dopamine agonist use.

1 reference

12 December 2020

Pathological gambling severity is associated with impulsivity in a delay discounting procedure.

1 reference

12 December 2020

Addiction: a disease of learning and memory

1 reference

12 December 2020

Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward.

1 reference

12 December 2020

Pathologic gambling in patients with Parkinson's disease

1 reference

12 December 2020

Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior.

1 reference

12 December 2020

Current issues in depression in Parkinson's disease

1 reference

12 December 2020

Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study

1 reference

12 December 2020

Clozapine/olanzapine-induced recurrence or deterioration of binge eating-related eating disorders.

1 reference

12 December 2020

Insensitivity to future consequences following damage to human prefrontal cortex

1 reference

12 December 2020

Pathological gambling secondary to dopaminergic therapy in Parkinson's disease

1 reference

12 December 2020

Pathological gambling and obsessive-compulsive spectrum disorders

1 reference

12 December 2020

Should addictive disorders include non-substance-related conditions?

1 reference

12 December 2020

1 reference

12 December 2020

Sertraline treatment of pathological gambling: a pilot study

1 reference

12 December 2020

Disabling repetitive behaviors in Parkinson's disease.

1 reference

12 December 2020

L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease

1 reference

12 December 2020

Prospective prevalence of pathologic gambling and medication association in Parkinson disease

1 reference

12 December 2020

Dopamine in drug abuse and addiction: results of imaging studies and treatment implications

1 reference

12 December 2020

Pathological gambling: addiction or compulsion?

1 reference

12 December 2020

Gambling: an addictive behavior with health and primary care implications

1 reference

12 December 2020

Hypersexuality after right pallidotomy for Parkinson's disease

1 reference

12 December 2020

The neurobiology of dopamine signaling

1 reference

12 December 2020

Internet gambling and other pathological gambling in Parkinson's disease: a case series

1 reference

12 December 2020

By carrot or by stick: cognitive reinforcement learning in parkinsonism

1 reference

12 December 2020

Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability

1 reference

12 December 2020

Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation

1 reference

12 December 2020

'Behavioral' addictions: do they exist?

1 reference

12 December 2020

Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling

1 reference

12 December 2020

Gambling and Parkinson disease

1 reference

12 December 2020

Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial

1 reference

12 December 2020

Personality, addiction, dopamine: insights from Parkinson's disease

1 reference

12 December 2020

The relationship between impulsivity and impulse control disorders in Parkinson's disease

1 reference

12 December 2020

N-acetyl cysteine-induced blockade of cocaine-induced reinstatement

1 reference

12 December 2020

Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial.

1 reference

12 December 2020

Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine

1 reference

12 December 2020

Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation

1 reference

12 December 2020

Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.

1 reference

12 December 2020

Preference for immediate over delayed rewards is associated with magnitude of ventral striatal activity.

1 reference

12 December 2020

Impulse control disorders in adult psychiatric inpatients.

1 reference

12 December 2020

Functional abnormalities underlying pathological gambling in Parkinson disease

1 reference

12 December 2020

Psychiatric aspects of impulsivity.

1 reference

12 December 2020

Effectiveness of community-based treatment for problem gambling: a quasi-experimental evaluation of cognitive-behavioral vs. twelve-step therapy.

1 reference

12 December 2020

The PRIAMO study: background, methods and recruitment.

1 reference

12 December 2020

Compulsive aspects of impulse-control disorders

1 reference

12 December 2020

Gastric stimulation in obese subjects activates the hippocampus and other regions involved in brain reward circuitry

1 reference

12 December 2020

Enhanced food-related motivation after bilateral lesions of the subthalamic nucleus.

1 reference

12 December 2020

Motivation, reward, and Parkinson's disease: influence of dopatherapy.

1 reference

12 December 2020

Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?

1 reference

12 December 2020

Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists

1 reference

12 December 2020

Functional activity related to risk anticipation during performance of the Iowa Gambling Task

1 reference

12 December 2020

Predictors of adolescent psychopathy: the role of impulsivity, hyperactivity, and sensation seeking.

1 reference

12 December 2020

Topiramate for the treatment of kleptomania: a case series and review of the literature

1 reference

12 December 2020

The neural basis of drug craving: an incentive-sensitization theory of addiction

1 reference

12 December 2020

Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease

1 reference

12 December 2020

Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?

1 reference

12 December 2020

Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease

1 reference

12 December 2020

Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study

1 reference

12 December 2020

Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling

1 reference

12 December 2020

The neural basis of addiction: a pathology of motivation and choice

1 reference

12 December 2020

Severity of gambling is associated with physical and emotional health in urban primary care patients

1 reference

12 December 2020